Inventor · disambiguated record
Bradley Backes
Also filed as: BACKES BRADLEY · BACKES BRADLEY J
14 granted patents·9 pending applications·166 citations·filing 2001–2021
88Inventor score
Top patents by PatentIndex Score
23 records- 0196US6680178B2Profiling of protease specificity using combinatorial fluorogenic substrate librariesUNIV CALIFORNIA·Filed 2001·Granted Jan 20, 2004·141 cites·112 claims
- 0279US10822340B2Substituted imidazolopyrazine compounds and methods of using sameUNIV CALIFORNIA·Filed 2018·Granted Nov 3, 2020·3 cites·42 claims
- 0377US10131668B2Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1UNIV CALIFORNIA·Filed 2015·Granted Nov 20, 2018·3 cites·20 claims
- 0472US9988368B1Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical useUNITY BIOTECHNOLOGY INC·Filed 2017·Granted Jun 5, 2018·1 cites·19 claims
- 0571US7329393B2Capacity altering device, holder, and methods of sample processingIRM LLC·Filed 2003·Granted Feb 12, 2008·17 cites·11 claims
- 0670US7834012B2Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)ABBOTT LAB·Filed 2006·Granted Nov 16, 2010·1 cites·10 claims
- 0761US11613544B2Substituted imidazo[1,5-a]pyrazines for modulation of IRE1UNIV CALIFORNIA·Filed 2020·Granted Mar 28, 2023·0 cites·20 claims
- 0861US7629437B2Fluorogenic materials and uses thereofUNIV CALIFORNIA·Filed 2003·Granted Dec 8, 2009·0 cites·31 claims
- 0958US11840523B2IRE1α inhibitors and uses thereofUNIV CALIFORNIA·Filed 2021·Granted Dec 12, 2023·0 cites·17 claims
- 1056US11884649B2IRE1α inhibitors and uses thereofUNIV CALIFORNIA·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 1156US10329279B2Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical useUNITY BIOTECHNOLOGY INC·Filed 2018·Granted Jun 25, 2019·0 cites·18 claims
- 1255US2009023572A1Capacity altering device, holder, and methods of sample processingIRM LLC·Filed 2008·Application pending·0 cites
- 1355US2019270726A1Products of chiral synthesis of cis-imidazoline compounds and their useUNITY BIOTECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 1449US2004009911A1Hepsin substrates and prodrugsIRM LLC·Filed 2003·Application pending·0 cites
- 1549US2003059847A1Combinatorial protease substrate librariesIRM LLC·Filed 2002·Application pending·0 cites
- 1648US2005153306A1Fluorogenic enzyme substrates and uses thereofIRM LLC·Filed 2004·Application pending·0 cites
- 1747US2023348364A1Isotopic thyromimetic compoundsAUTOBAHN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1846US2006264433A1Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)BACKES BRADLEY J·Filed 2006·Application pending·0 cites
- 1944US2021009551A1Compounds and methods for treating fibrosis or cancerUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 2042US12391669B2Substituted pyrimidines as IRE1 kinase inhibitorsUNIV CALIFORNIA·Filed 2019·Granted Aug 19, 2025·0 cites·18 claims
- 2141US2017165259A1Combined modulation of ire1UNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 2237US11111259B2Acylsulfonamide derivatives for treating senescence-associated diseases and disordersUNITY BIOTECHNOLOGY INC·Filed 2016·Granted Sep 7, 2021·0 cites·18 claims
- 2335US11649237B2Substituted imidazo[1,5-a]pyrazines for IRE1 inhibitionOPTIKIRA LLC·Filed 2018·Granted May 16, 2023·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Bradley Backes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →